COMPOUND OYSTER PEPTIDE
NDC 85631-004, COMPOUND OYSTER PEPTIDE, capsule, from Bispit Canada Ltd..
- Product NDC
- 85631-004
- Status
- Listed
- Labeler
- Bispit Canada Ltd.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/85631-004 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LYCIUM CHINENSE FRUIT270 mg/1.2g
- ASIAN GINSENG180 mg/1.2g
- LICORICE24 mg/1.2g
- POLYGONATUM SIBIRICUM WHOLE90 mg/1.2g
- PHYLLOLOBIUM CHINENSE SEED72 mg/1.2g
- RIBOFLAVIN.24 mg/1.2g
- ZINC LACTATE5.16 mg/1.2g
- TAURINE30 mg/1.2g
- THIAMINE.6 mg/1.2g
- CORNUS OFFICINALIS WHOLE180 mg/1.2g
- SEA CUCUMBER, UNSPECIFIED120 mg/1.2g
- DIOSCOREA CAYENENSIS TUBER96 mg/1.2g
- WHITE MULBERRY72 mg/1.2g
- OYSTER, UNSPECIFIED12 mg/1.2g
Pharmacologic classes
Allergens [CS]; Cell-mediated Immunity [PE]; Copper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]; Non-Standardized Food Allergenic Extract [EPC]; Shellfish Proteins [EXT]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 85631-004-01 | 85631000401 | 60 CAPSULE in 1 BOTTLE (85631-004-01) / 1.2 g in 1 CAPSULE |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 85631-004 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/85631-004 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 85631-004. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.